QA: Myokardia Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001552451_2020_Myokardia_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001552451, Myokardia Inc

  xvar xval
0 AssetsCurrent 423,836,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 15,743,000
3 remainder_Assets 16,515,000
4 LiabilitiesCurrent 47,912,000
5 LiabilitiesNoncurrent 1,908,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 177,732,599
9 ResearchAndDevelopmentExpense 532,849,310
10 remainder_Expenses 80,000,000
11 remainder_Revenues 32,757,386
12 remainder_NetIncome 12,333,416
13 remainder_ComprehensiveNetIncome 1,310,205
  yvar yval
0 Assets 456,094,000
1 Liabilities 49,820,000
2 Expenses 790,581,909
3 Revenues 32,757,386
4 StockholdersEquity 406,274,000
5 NetIncome -745,491,107
6 ComprehensiveNetIncome -744,836,004
7 BaseVar 671,448,458
8 EconomicCapitalRatiobeforeLimitedLiability 0.557
9 EconomicCapitalRatio 1.93

Edgar->Model Mapping

Feature Distribution

Change over Time